What We Do
Solid form patents and polymorph patent strategy for pharmaceutical products
Solid form patent strategy consulting for pharma teams
Solid form patents protect specific crystalline forms that make a drug work better in the real world. Barash Law helps companies identify and claim polymorphs, salts, cocrystals, and amorphous forms so protection goes beyond the core compound. Many clients file these secondary patents after a composition-of-matter filing to strengthen exclusivity. From Lafayette, Indiana near Purdue University and the Wabash River, Barash Law supports life science teams across the United States and Europe through a virtual model that fits R&D schedules.
Why solid form patents matter for exclusivity and Orange Book
Solid form patents can qualify as Orange Book drug substance listings when claims cover the active ingredient’s specific crystal form. That listing can deter generic entry and support regulatory strategy. For products where the original patent is limited, solid form IP may be the only drug substance protection available. Barash Law brings long-standing solid-state chemistry and pharmaceutical patent experience to this work.
Let's Talk